Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

Page Options

Clinical Trial Questions?

Get Help:

	Quick Links


	Help Using the NCI Clinical Trials Search Form Educational Materials About Clinical Trials About NCI's Cancer Clinical Trials Registry Dictionary of Cancer Terms NCI Drug Dictionary

View Content for:

Patients
Health Professionals

Display:

Title
Description with: Locations Eligibility
Full Trial Description
Custom

Results 1-5 of 5 for your search:

Cancer Type/Condition:  Lip and oral cavity cancer
Trial Type:  Prevention
Treatment/Intervention:  chemoprevention
Trial Status:  Active

Help with Results

Select All on Page Sort by: Show Results per Page

Erlotinib Prevention of Oral Cancer (EPOC)

Phase: Phase III
Type: Prevention
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 2003-0824, EPOC, NCT00402779

Secondary Primary Tumor Prevention With EGFR, OSI-774, and Cyclooxygenase-2

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 0405-2006, NCT00400374

Phase I/II Study of Chemoprevention With EGFR and COX-2 Inhibitor

Phase: Phase II, Phase I
Type: Prevention
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 0596-2004, NCT00314262

Bowman-Birk Inhibitor Concentrate in Preventing Cancer in Patients With Oral Leukoplakia

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: UCIRVINE-UCI-98-34, UCIRVINE-UCI-1998-521, NCT00330382, U01-CA-72294

A Randomized Study of Sulindac in Oral Premalignant Lesions

Phase: No phase specified
Type: Prevention
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: 04-099, NCT00299195

Select All on Page

Help with Results

| | | | | | | | |

A Service of the National Cancer Institute